MAP Pharmaceuticals

Showing 1 posts of 1 posts found.

Allergan in $958m neurology deal

January 25, 2013
Sales and Marketing Allergan, CNS, MAP Pharmaceuticals, migraine

Allergan is to pay $958m for MAP Pharmaceuticals in a deal which sees both companies hoping to reap the benefits …

The Gateway to Local Adoption Series

Latest content